SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 15
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 12 13 14 15
|
presentations:
1 to
50 of
713
|
US National and State HIV Prevention Funding Trends Against HIV Diagnosis Rates From 2008 to 2023 (ABSTRACT
1055)
Evan Hall
Botswana Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana
Real-World Outcomes of Tirzepatide Use in People With HIV With and Without Diabetes (ABSTRACT
696)
Daniel Lee
UCSD Medical Center Owen Clinic, San Diego, CA, USA
Association Between Mpox Vaccination and Disease Severity in Washington State, 2023-2025 (ABSTRACT
321)
Benjamin Meana
Washington State Department of Health, Olympia, WA, USA
Tecovirimat Treatment of Mpox Leads to Emergent Resistance in Advanced HIV (ACTG A5418/STOMP) (ABSTRACT
502)
Alex Greninger
University of Washington, Seattle, WA, USA
Perinatal CMV Coinfection Influences the HIV Reservoir in Individuals With Perinatally Acquired HIV (ABSTRACT
835)
Nicole Colantoni
Ospedale Pediatrico Bambino Gesu, Rome, Italy
RV534 Trial: T-Cell Responses and HIV Reservoir Change in HIVIS-DNA/MVA-CMDR+TLR4 Vaccinated Youth (ABSTRACT
847)
Arianna Rotili
University of Rome Tor Vergata, Rome, Italy
Validity of Point-of-Care Urine Tenofovir Testing to Differentiate Viremia Versus Suppression on TLD (ABSTRACT
508)
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
Short Text Messages Improve Antiretroviral Adherence Among People Living With HIV in Georgia (ABSTRACT
509)
Otar Chokoshvili
T. Tsertsvadze Infectious Diseases AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
Majority of Infected Cells in Peripheral Blood of PWH on ART Transcribe Cell-Associated HIV gag RNA (ABSTRACT
356)
Alexander Pasternak
Amsterdam University Medical Centers, Amsterdam, Netherlands
Two Years of Dolutegravir (DTG) Use Did Not Affect Body Composition in People Without HIV Infection (ABSTRACT
688)
Cleyde S. C. Marconi
Federal University of Bahia, Salvador, Brazil
Mitochondrial Function and Cardiometabolic Health in People With HIV in South Africa and Kenya (ABSTRACT
707)
Hans Strijdom
Stellenbosch University, Cape Town, South Africa
Effect of Initiating Dolutegravir and Efavirenz-Based ART on the Vaginal Microbiota in Pregnancy (ABSTRACT
807)
Charlotte-Eve Short
Imperial College London, London, UK
Simple Adiposity Measures Identify MASLD in People With HIV: Results From a US Multicenter Cohort (ABSTRACT
599)
Kara Wegermann
Duke University School of Medicine, Durham, NC, USA
Prevalence of Steatotic Liver Disease in Pregnant South African Women Living With and Without HIV (ABSTRACT
602)
Mustafa Shuaib
University of Cape Town, Cape Town, South Africa
Prevalence and Risk Factors for Steatotic Liver Disease in PWH With Resolved HCV (ABSTRACT
603)
Kara Wegermann
Duke University School of Medicine, Durham, NC, USA
Elevated Triglyceride and Ceramide Metabolites in MASLD Among PWH (ABSTRACT
606)
Kara Wegermann
Duke University School of Medicine, Durham, NC, USA
Sexually Transmitted Enteric Infections in Southern Taiwan, 2019-2024 (ABSTRACT
1023)
Chin-Shiang Tsai
National Cheng Kung University Hospital, Tainan, Taiwan
Development of a Fluorescence Immunoassay for Measuring HIV Antibodies and Soluble gp120 in PLWH (ABSTRACT
236)
Alan F. Garcia
University of Hawaii at Manoa, Honolulu, HI, USA
Comparing Molecular and Time-Space HIV Cluster Detection Methods in Rural Washington, 2020-2024 (ABSTRACT
876)
Nicole Adams
Washington State Department of Health, Olympia, WA, USA
Risk Factors of HIV/AIDS Mortality Among HIV Recipients of Care in Southern Nigeria (ABSTRACT
906)
Afeez Oyetola
Howard University Global Initiative Nigeria
Phase III Efficacy and Safety of Switch From B/F/TAF to Single-Tablet BIC/LEN in ARTISTRY-2 (ABSTRACT
513)
Eric Meissner
Medical University of South Carolina, Charleston, SC, USA
Once-Weekly Islatravir Plus Lenacapavir Maintains HIV-1 Suppression Through 96 Weeks: Phase II Study (ABSTRACT
516)
Amy Colson
Community Resource Initiative, Boston, MA, USA
RCT of Mobile Health Unit Versus Patient Navigation to Increase PrEP in Criminal Legal-Involved PWUD (ABSTRACT
1071)
Sandra A. Springer
Yale University, New Haven, CT, USA
Closing PrEP Access Gaps: Results From the First Legalized Mobile Retail Pharmacy Clinic (ABSTRACT
1075)
Sandra A. Springer
Yale University, New Haven, CT, USA
Gaps in Care Transitions Between Perinatal and Postpartum Care for Chronic Hepatitis B Infection (ABSTRACT
800)
M. Elle Saine
Hospital of the University of Pennsylvania, Philadelphia, PA, USA
Rectal Microbiome Associations With HIV Vaccine-Induced Binding Antibody Responses in RV306 (ABSTRACT
285)
Nel Marín-Sánchez
IrsiCaixa, Badalona, Spain
Impact of Doxycycline Postexposure Prophylaxis on Antibiotic Use at a Boston Sexual Health Clinic (ABSTRACT
1047)
Rachel Mittelstaedt
Massachusetts General Hospital, Boston, MA, USA
Clinician vs Self-Collected Anal Pap Tests in a Large Ryan White Clinic in the US South (ABSTRACT
638)
Hayden Andrews
University of Texas Southwestern Medical Center, Dallas, TX, USA
AAV-Delivered Antibody Reaches Mucosal Sites and Protects Against SHIV Infection in Rhesus Macaques (ABSTRACT
294)
Luanna E. L. Vidal
University of Miami, Miami, FL, USA
Depression and Inflammation in Acute HIV: An RDoC-Based PHQ-9 Factor Analysis (ABSTRACT
477)
Veronica Wright
Kimbrough Ambulatory Care Center, Fort Meade, MD, USA
IRE1α–XBP1 Pathway Mediates gp120-Induced Microglial Inflammation and Is Inhibited by TREM1 Blockade (ABSTRACT
478)
Ayisha Mahama
University of South Dakota, Vermillion, SD, USA
Altered Choline and Sphingolipid Metabolism in HTLV-1-Associated Myelopathy (ABSTRACT
480)
Jorge Casseb
Universidade de São Paulo, São Paulo, Brazil
Pilot Validation of an Enzymatic Assay With Lateral Flow Readout for Long-Term PrEP Adherence (ABSTRACT
960)
Carrie H. Lin
University of Washington, Seattle, WA, USA
IL-6 Inhibits T-Cell Lineage Commitment of HSPCs During Pathogenic Retroviral Infection (ABSTRACT
259)
Sheikh A. Rahman
Emory University, Atlanta, GA, USA
Characterizing SIV-Infected Plasmacytoid Dendritic Cell Aggregates in Rhesus Macaque Lymph Nodes (ABSTRACT
260)
Elizabeth A. Urban
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single-Dose Study (ABSTRACT
796)
Angela D. M. Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
CA T107 Polymorphisms in HIV-1 From Lenacapavir-Naive PLWH Do Not Confer or Enhance Resistance (ABSTRACT
579)
Ella Begovic
University of Pittsburgh, Pittsburgh, PA, USA
PositiveLinks for Youth (PL4Y): Promising Results of a Pilot mHealth Intervention for Youth With HIV (ABSTRACT
1112)
Barbara S. Taylor
University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
A Roadmap to New Models for Long-Acting Injectable Antiretroviral Administration (ABSTRACT
1113)
Corrilynn O. Hileman
MetroHealth Medical Center, Cleveland, OH, USA
Implementing Self-Screening for Extragenital Chlamydia and Gonorrhea in Low-Resource US Settings (ABSTRACT
1096)
Loren M. Dobkin
University of Michigan, Ann Arbor, MI, USA
Global Cohort Analysis of Dolutegravir Viral Response in Children and Adolescents Living With HIV (ABSTRACT
860)
Joycelyn A. Dame
University of Ghana Medical School, Accra, Ghana
Incidence of Intended & Unintended Pregnancies Among Women With HIV on ART: 5-Year Cohort in Abidjan (ABSTRACT
1252)
Prescilia Visi Vumba
University of Bordeaux, Bordeaux, France
PrEP Eligible but Missed: Preliminary Evidence Unlocking the Potential of Family Planning Services (ABSTRACT
1255)
Brenice Duroseau
The Johns Hopkins University, Baltimore, MD, USA
STAR: A Prospective Cohort of Women of Reproductive Age With and Without HIV in the Southern US (ABSTRACT
1258)
Elizabeth F. Topper
The Johns Hopkins University, Baltimore, MD, USA
Neuropsychiatric Outcomes in Adults With HIV and TB on Twice-Daily BIC/FTC/TAF With Rifampicin (ABSTRACT
951)
Gillian L. Dorse
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
Plasma CNS Tissue Markers in Heavily Treatment-Experienced PWH in the PRESTIGIO Registry (ABSTRACT
600)
Andrea Calcagno
University of Turin, Turin, Italy
Higher suPAR Relates to Domain-Specific Cognitive Function in Virally Suppressed Women With HIV (ABSTRACT
602)
Hemil Gonzalez
Rush University Medical Center, Chicago, IL, USA
Epigenetic Age Acceleration and CD4/CD8 Ratio in People With Well-Controlled HIV Infection (ABSTRACT
867)
Alejandro de Gea Grela
Hospital La Paz Institute for Health Research, Madrid, Spain
Validation of SARC-F Tool for Sarcopenia Screening in People Aging With HIV (ABSTRACT
871)
Joselito Malca Hernandez
Yale University, New Haven, CT, USA
TCR Convergence in HIV Controllers: Insights Into Natural Viral Suppression (ABSTRACT
404)
Alexandra Vujkovic
Institute of Tropical Medicine, Antwerp, Belgium
|
<< first | < prev
page:
of 15
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 12 13 14 15
|
presentations:
1 to
50 of
713
|
